Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-072595
Filing Date
2025-05-15
Accepted
2025-05-15 16:05:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11184
2 EX-99.A ck0001669811-ex99_a.pdf EX-99.A 108831
  Complete submission text file 0000950170-25-072595.txt   163106
Mailing Address P.O. BOX 656, EAST WING, TRAFALGAR COURT LES BANQUES ST PETER PORT Y7 GY1 3PP
Business Address P.O. BOX 656, EAST WING, TRAFALGAR COURT LES BANQUES ST PETER PORT Y7 GY1 3PP 44 1481 749 714
Endeavour Medtech Growth II LP (Filed by) CIK: 0001873032 (see all company filings)

EIN.: 981530409 | State of Incorp.: Y7 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033
Business Address 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033 (425) 279-8002
KESTRA MEDICAL TECHNOLOGIES, LTD. (Subject) CIK: 0001877184 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0430
Type: SCHEDULE 13G | Act: 34 | File No.: 005-95012 | Film No.: 25952684
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)